Quick Facts: Medical Cannabis in Rwanda
| Legal Status | Export Licensed Only |
|---|---|
| Medical Programme Since | 2021 (export licences) |
| Adult Use | Illegal |
| Access Type | No domestic medical programme; possession remains criminal |
| Est. Monthly Cost | Not applicable (no domestic programme) |
Overview
Rwanda established a cannabis export licensing framework in 2021, permitting licensed companies to cultivate cannabis for international medical markets. This was an economic decision: Rwanda positioned itself to supply the growing global medical cannabis industry. However, there is no domestic medical cannabis patient programme. Cannabis possession for personal use remains a criminal offence in Rwanda. The country's cannabis industry exists entirely for export.
How to Access Medical Cannabis in Rwanda
- No domestic access available — Rwanda does not have a domestic medical cannabis patient programme. There is no legal route for Rwandan patients to access medical cannabis within the country.
- Consult a physician for alternatives — Patients should consult physicians for conventional pharmaceutical pain management, anticonvulsants or other evidence-based treatments available through Rwanda's healthcare system.
- Consider medical tourism for serious cases — Patients with serious conditions requiring cannabis may consider medical travel to South Africa (SAHPRA programme) or Israel, both of which have accessible patient programmes.
- Monitor policy developments — Rwanda's government may expand from export-only to include a domestic programme in the future as the industry matures.
Qualifying Conditions
- No formal qualifying conditions (no domestic programme)
- Conditions that might qualify internationally: epilepsy, chronic pain, cancer, palliative care
Cost and Access Details
There is no domestic medical cannabis market in Rwanda. All licensed cannabis production is for export. Rwandan patients who access cannabis internationally face the costs of medical travel plus the cost of the programme in the destination country.
Frequently Asked Questions
Does Rwanda have a medical cannabis programme for patients?
No. Rwanda's 2021 cannabis licences are exclusively for export production. There is no domestic patient programme, and possession of cannabis for personal use remains a criminal offence.
Why did Rwanda legalise cannabis if patients cannot use it?
Rwanda's decision was economically motivated. The country positioned itself to supply the rapidly growing global medical cannabis market, particularly European markets such as Germany, as a licensed regulated producer. It is an agricultural export strategy, not a patient access policy.
Is cannabis possession legal in Rwanda?
No. Cannabis possession remains a criminal offence in Rwanda regardless of the export licensing framework. Penalties include fines and imprisonment.
What cannabis companies operate in Rwanda?
Several international cannabis companies have obtained export licences in Rwanda, attracted by the country's stable governance, good climate and competitive growing conditions. These are cultivating for export to Germany, Switzerland and other markets.
Where can Rwandan patients access medical cannabis?
Rwandan patients requiring medical cannabis access must travel internationally. South Africa's SAHPRA programme and Israel's system are the most accessible options in the region.
Will Rwanda develop a domestic medical cannabis programme?
There has been some discussion of expanding Rwanda's framework to include domestic medical access, but as of 2026 no domestic programme has been announced. The export-first approach reflects government priorities.